Clinical Decision Support Systems (CDSS) Market Size is valued at 2.20 Billion in 2024 and is predicted to reach 5.13 Billion by the year 2034 at a 8.09 % CAGR during the forecast period for 2025-2034. A cllinical decision support system (CDSS) integrates particular clinical knowledge, patient data, and other health data into medical decisions to improve healthcare delivery. Globally prevalent chronic diseases and advances in big data processi...
Report ID: 1374 |
Delivery: Immediate |
Published: April 2025 |
No. of Pages: 180
Global Contraceptive Market Size is valued at USD 32.5 Billion in 2024 and is predicted to reach USD 69.0 Billion by the year 2034 at a 7.9% CAGR during the forecast period for 2025-2034. The use of contraception has increased, which has improved health outcomes, such as maternal and newborn mortality, and reduced the risk of STDs. Additionally, it is projected that an increase in the number of gynecologists who support these contraceptive metho...
Report ID: 1494 |
Delivery: Immediate |
Published: April 2025 |
No. of Pages: 180
Genetic Genealogy Market Size is valued at USD 971.17 Mn in 2024 and is predicted to reach USD 2187.61 Mn by the year 2034 at an 8.5% CAGR during the forecast period for 2025-2034. Numerous benefits of genetic analysis make it more necessary than ever among the global population. Genetic analysis offers possible medical benefits and assists patients, cancers, and healthcare providers in modifying the therapy and healthcare given to an individu...
Report ID: 2059 |
Delivery: Immediate |
Published: April 2025 |
No. of Pages: 180
Global PD-1 Inhibitor Drugs Market Size is valued at USD 40.5 Billion in the year 2024 and is predicted to reach USD 150.6 Billion by the year 2034 at an 14.4% CAGR during forecast period for 2025-2034. PD-1 inhibitors are cancer immunotherapies that inhibit the PD-1 receptor on T cells, hindering cancer cells from resisting immune recognition. Consequently, the immune system becomes strengthened, enhancing its ability to i...
Report ID: 2950 |
Delivery: Immediate |
Published: April 2025 |
No. of Pages: 180
Antibody Conjugate Oligonucleotide Market Size is predicted to develop with a 10.3% CAGR during the forecast period for 2025-2034. Antibody Conjugate Oligonucleotides (ACOs) are new drugs that combine the selectivity of antibody targeting with the gene-modulating capabilities of oligonucleotides. ACOs are a substantial advancement in precision medicine and oncology, as they selectively transport therapeutic oligonucleotides to target cells, mo...
Report ID: 2960 |
Delivery: Immediate |
Published: April 2025 |
No. of Pages: 180
The Neuroimmunology Drugs Market Size is valued at US$ 25.6 Bn in 2024 and is predicted to reach US$ 63.3 Bn by the year 2034 at an 9.7% CAGR during the forecast period for 2025-2034. The Neuroimmunology Drugs Market is growing very fast, driven by increasing knowledge of the complex interaction between the immune and nervous systems. These drugs are targeted to modulate immune reactions in neurological diseases resulting from immune dys...
Report ID: 1171 |
Delivery: Immediate |
Published: April 2025 |
No. of Pages: 180
Brachytherapy Seeds Market Size is valued at USD 137.7 Mn in 2024 and is predicted to reach USD 224.1 Mn by the year 2034 at a 5.2% CAGR during the forecast period for 2025-2034. Brachytherapy seeds, often used in permanent brachytherapy, are small radioactive pellets implanted directly into or near tumors to deliver localized radiation therapy. These seeds, typically the size of a grain of rice, contain radioactive isotopes such as iodine-125...
Report ID: 2968 |
Delivery: Immediate |
Published: April 2025 |
No. of Pages: 180
Global Targeted Protein Degradation Market Size is valued at USD 0.5 Billion in 2024 and is predicted to reach USD 5.5 Billion by the year 2034 at an 26.6% CAGR during the forecast period for 2025-2034. Targeted Protein Degradation (TPD) is a novel therapeutic strategy that harnesses the cell's natural protein disposal system to eliminate unwanted proteins. Instead of inhibiting a protein's activity, TPD molecules tag the protein for destruction...
Report ID: 2530 |
Delivery: Immediate |
Published: April 2025 |
No. of Pages: 180
Global Allergy Immunotherapy Market Size is valued at USD 1.9 Billion in 2024 and is predicted to reach USD 4.3 Billion by the year 2034 at an 8.5% CAGR during the forecast period for 2025-2034 Key Industry Insights & Findings from the Report: Investments in allergy immunotherapy research and development have been driven by the increasing healthcare expenditure worldwide, as well as the increased focus on customized medicine and targeted ...
Report ID: 1924 |
Delivery: Immediate |
Published: April 2025 |
No. of Pages: 180
Global Neoantigen Peptides Manufacturing Market Size is valued at USD 1.4 Billion in 2024 and is predicted to reach USD 6.3 Billion by the year 2034 at a 16.4% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The increasing prevalence of cancer as well as other chronic illnesses is a major factor driving the growth of the neoantigen peptides manufacturing market. Rapid progre...
Report ID: 1270 |
Delivery: Immediate |
Published: April 2025 |
No. of Pages: 170
Pharmaceuticals